These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 15016223)

  • 1. Diabetic autoimmunity in infants and pre-schoolers with type 1 diabetes.
    Hathout EH; Sharkey J; Racine M; Thomas W; Nahab F; El-Shahawy M; Mace JW
    Pediatr Diabetes; 2000 Sep; 1(3):131-4. PubMed ID: 15016223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
    Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
    Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamic acid decarboxylase autoantibody prevalence and association with HLA genotype in patients with younger-onset type 1 diabetes and proliferative diabetic retinopathy.
    Mimura T; Funatsu H; Uchigata Y; Kitano S; Shimizu E; Amano S; Yamagami S; Noma H; Araie M; Hori S
    Ophthalmology; 2005 Nov; 112(11):1904-9. PubMed ID: 16157380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and immunological characteristics in rapid-onset type 1 diabetes with hyperamylasemia].
    Zhang C; Zhou ZG; Zhang DM; Yang XL; Zhou M; Lin J; Huang G; Wang JP
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):967-71. PubMed ID: 16061004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital.
    Römkens TE; Kusters GC; Netea MG; Netten PM
    Neth J Med; 2006 Apr; 64(4):114-8. PubMed ID: 16609158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for preclinical type 1 diabetes in a discrete population with an apparent increased disease incidence.
    Colman PG; McNair P; King J; Caudwell J; Jankulovski C; Tait BD; Honeyman MC; Harrison LC
    Pediatr Diabetes; 2000 Dec; 1(4):193-8. PubMed ID: 15016215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.
    Tiberti C; Giordano C; Locatelli M; Bosi E; Bottazzo GF; Buzzetti R; Cucinotta D; Galluzzo A; Falorni A; Dotta F
    Diabetes; 2008 May; 57(5):1276-83. PubMed ID: 18332100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 diabetes-related epidemiological, clinical and laboratory findings. An evaluation with special regard to autoimmunity in children.
    Karaguzel G; Ozer S; Akcurin S; Turkkahraman D; Bircan I
    Saudi Med J; 2007 Apr; 28(4):584-9. PubMed ID: 17457482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E; Hallengren B; Agardh CD
    Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing presentation of children with newly diagnosed type 1 diabetes mellitus.
    Jackson W; Hofman PL; Robinson EM; Elliot RB; Pilcher CC; Cutfield WS
    Pediatr Diabetes; 2001 Dec; 2(4):154-9. PubMed ID: 15016180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus.
    Arikan E; Sabuncu T; Ozer EM; Hatemi H
    J Diabetes Complications; 2005; 19(5):254-8. PubMed ID: 16112499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permanent diabetes mellitus in the first year of life.
    Iafusco D; Stazi MA; Cotichini R; Cotellessa M; Martinucci ME; Mazzella M; Cherubini V; Barbetti F; Martinetti M; Cerutti F; Prisco F;
    Diabetologia; 2002 Jun; 45(6):798-804. PubMed ID: 12107723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
    Pietropaolo M; Yu S; Libman IM; Pietropaolo SL; Riley K; LaPorte RE; Drash AL; Mazumdar S; Trucco M; Becker DJ
    Pediatr Diabetes; 2005 Dec; 6(4):184-92. PubMed ID: 16390386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus.
    Gupta M; Graham J; McNeeny B; Zarghami M; Landin-Olsson M; Hagopian WA; Palmer J; Lernmark A; Sanjeevi CB
    Ann N Y Acad Sci; 2006 Oct; 1079():229-39. PubMed ID: 17130560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
    Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R;
    Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic autoantibodies in Italian patients with newly diagnosed type 1 diabetes mellitus over the age of 20 years.
    Betterle C; Lazzarotto F; Fusari A; Zanchetta R; Benedini S; Pedini B; Moscon A; Presotto F
    Acta Diabetol; 2006 Nov; 43(3):79-83. PubMed ID: 17143785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.
    Buzzetti R; Di Pietro S; Giaccari A; Petrone A; Locatelli M; Suraci C; Capizzi M; Arpi ML; Bazzigaluppi E; Dotta F; Bosi E;
    Diabetes Care; 2007 Apr; 30(4):932-8. PubMed ID: 17392553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic autoimmune markers in children and adolescents with type 2 diabetes.
    Hathout EH; Thomas W; El-Shahawy M; Nahab F; Mace JW
    Pediatrics; 2001 Jun; 107(6):E102. PubMed ID: 11389300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GADA and islet cell antibodies in Romanian children and adolescents with diabetes mellitus.
    Serban V; Enache A; Vlad A; Sima A; Roşu M; Roşca A; Drăghici C
    Rom J Intern Med; 2004; 42(2):325-32. PubMed ID: 15529623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes.
    Castleden HA; Shields B; Bingley PJ; Williams AJ; Sampson M; Walker M; Gibson JM; McCarthy MI; Hitman GA; Levy JC; Hattersley AT; Vaidya B; Pearson ER
    Diabet Med; 2006 Aug; 23(8):834-8. PubMed ID: 16911619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.